Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications. May 3, 2017
1001. Neurocognitive Effects of Repeated Ketamine Infusions in Co-Occurring Posttraumatic Stress Disorder and Treatment-Resistant Depression April 29, 2017
Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial April 28, 2017
Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders April 26, 2017
Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment April 23, 2017
Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin April 19, 2017
New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity April 11, 2017
Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain April 7, 2017
A proof-of-concept investigation into ketamine as a pharmacological treatment for alcohol dependence: study protocol for a randomised controlled trial April 4, 2017
Clinical predictors of antidepressant response to ketamine in unipolar treatment-resistant depression April 1, 2017
